title: The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil.
abstract: First noted in the city of Teresina in 1981, the last decades have witnessed a remarkable increase in urban transmission of American visceral leishmaniasis (VL) in many Brazilian cities. Teresina, the site of this study, has faced two large outbreaks of VL. The first occurred from 1981-1985 when almost 1000 new cases were reported. The second started in the 1990s, and between 1993 and 1996 more than 1200 new cases were detected. This report describes the prevalence of infection with Leishmania chagasi in Teresina at the end of the second outbreak and gives estimates of the number of people who became infected during the epidemic. Between June 1995 and May 1996, 200 households were chosen at random from a list of addresses covering about 93% of Teresina's urban households. In each household, one person over the age of 1 year was screened for Leishmania antibodies and skin-tested. Nearly 50% of persons had a positive leishmanin reaction, but only 13.9% had detectable antibodies to L. chagasi. While prevalence estimates based on the leishmanin skin-test increased with age (P<0.001), those based on serological tests showed a lesser, and non significant, variation with age (P=0.31). Using a geometric growth equation, and assuming that the annual distribution of clinical cases may serve as an approximation to what would have been the distribution of infections by year, we estimated that over 320000 persons were infected during the epidemic. Little is known about the epidemiology of VL in urban areas, where social networks, population density, and relationships of housing with the natural environment are more varied and complex than in the rural scene. In those areas, control interventions have failed to eliminate transmission of the parasite and prevent new epidemics. Further epidemiological studies of VL in urban areas might be needed to inform control actions.
authors.affiliation: Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA. gwerneck@malaria.procc.fiocruz.br
authors.forename: G L
authors.initials: GL
authors.lastname: Werneck
authors.forename: L
authors.initials: L
authors.lastname: Rodrigues
authors.forename: M V
authors.initials: MV
authors.lastname: Santos
authors.forename: I B
authors.initials: IB
authors.lastname: Araújo
authors.forename: L S
authors.initials: LS
authors.lastname: Moura
authors.forename: S S
authors.initials: SS
authors.lastname: Lima
authors.forename: R B B
authors.initials: RB
authors.lastname: Gomes
authors.forename: J H
authors.initials: JH
authors.lastname: Maguire
authors.forename: C H N
authors.initials: CH
authors.lastname: Costa
mesh_terms: D000293:Adolescent; D000328:Adult; D000913:Antibodies, Protozoan / Q000302:isolation & purification; D001938:Brazil / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D006801:Humans; D007223:Infant; D007898:Leishmaniasis, Visceral / Q000453:epidemiology* / Q000276:immunology; D015995:Prevalence; D016036:Seroepidemiologic Studies; D014505:Urban Population
chemical_list: D000913:Antibodies, Protozoan